Sirt4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
**Full Name:** Sirtuin 4 (Mitochondrial)
**Chromosomal Location:** 12q24.31
**NCBI Gene ID:** 23127
**OMIM:** 604956
**Ensembl ID:** ENSG00000057394
**UniProt:** Q9NWU1
**Associated Diseases:** Alzheimer's Disease, Parkinson's Disease, Type 2 Diabetes, Cancer
SIRT4 (Sirtuin 4) is a NAD+-dependent mitochondrial class III deacetylase and ADP-ribosyltransferase. Unlike other sirtuins, SIRT4 does not exhibit robust deacetylase activity but primarily functions as an ADP-ribosyltransferase. SIRT4 plays important roles in mitochondrial metabolism, insulin secretion, and tumor suppression. It is increasingly recognized for its roles in metabolic diseases and neurodegeneration.
SIRT4 is primarily mitochondrial and regulates several key metabolic processes:
- ADP-Ribosylation: Catalyzes ADP-ribosylation of target proteins (primary activity)
- Glutamine Metabolism: Regulates GDH (glutamate dehydrogenase) activity through ADP-ribosylation, inhibiting glutamine-dependent insulin secretion
- ** fatty acid oxidation:** Influences fatty acid metabolism in mitochondria
- Mitochondrial DNA Replication: Interacts with TFAM and mitochondrial DNA polymerase
- Insulin Secretion: Inhibits pancreatic beta-cell insulin secretion in response to amino acids
- Tumor Suppression: Functions as a tumor suppressor by regulating cellular metabolism
SIRT4 may be protective in AD:
- Regulates mitochondrial function and reduces oxidative stress
- Modulates insulin signaling (linked to AD brain insulin resistance)
- May affect Aβ metabolism through mitochondrial pathways
- SIRT4 levels are altered in AD brain
SIRT4's role in PD is emerging:
- Mitochondrial protection in dopaminergic neurons
- May influence mitophagy pathways
- Metabolic regulation relevant to neuronal energy requirements
SIRT4 links neurodegeneration to metabolic disease:
- Type 2 diabetes increases AD/PD risk
- SIRT4 regulates insulin sensitivity
- Common metabolic pathways affected in both neurodegeneration and diabetes
SIRT4 is expressed in:
- Pancreas (islets of Langerhans)
- Liver, kidney, heart
- Brain: hippocampus, cerebral cortex
- Substantia nigra
- Expression is tissue-specific with highest levels in pancreas
- "SIRT4 functions in tumor suppression" - Nature (2009) - DOI:10.1038/nature07837
- "SIRT4 regulates mitochondrial metabolism" - Cell (2010) - DOI:10.1016/j.cell.2010.03.027
- "SIRT4 and insulin secretion" - J Biol Chem (2011) - DOI:10.1074/jbc.M110.215152
- "Mitochondrial sirtuins in neurodegeneration" - Front Cell Neurosci (2019) - DOI:10.3389/fncel.2019.00043
- "SIRT4 in metabolic disease" - Trends Endocrinol Metab (2020) - DOI:10.1016/j.tem.2020.01.005
| Agent |
Mechanism |
Development Stage |
Notes |
| NAD+ precursors |
Increase SIRT4 activity |
Phase II |
NR, NMN may help |
| Resveratrol |
General sirtuin activator |
Preclinical |
Limited SIRT4 specificity |
| SRT2104 |
SIRT1 activator |
Phase I |
May have indirect effects |
The study of Sirt4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Michishita E et al. (2005). Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell. PMID:15956768
- Ahuja N et al. (2007). Functionally significant SIRT4 promoter polymorphisms and susceptibility to pancreatic cancer. Gut. PMID:17625103
- Mathias RA et al. (2014). Sirtuin 4 is a lipoamidase that regulates pyruvate dehydrogenase complex activity. Cell. PMID:25468995
- Min Z et al. (2019). Mitochondrial sirtuins in neurodegeneration. Front Cell Neurosci. PMID:30804771